RHYTHM PHARMACEUTICALS INC (RYTM) Institutional Shareholders

RHYTHM PHARMACEUTICALS INC (RYTM) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $8.44B in RYTM holdings during the latest filing period.

Ra Capital Management, L.P. is currently the largest disclosed institutional shareholder of RYTM tracked by InsiderSet, reporting ownership valued at approximately $740.22M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $653.42M, representing an estimated loss of -11.73% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 50% of the total disclosed RYTM value among the investors covered in this analysis. Major shareholders include Ra Capital Management, L.P., Blackrock, Inc., Baker Bros. Advisors Lp, and several other long-term asset managers with concentrated positions in RHYTHM PHARMACEUTICALS INC (RYTM).

This page ranks the largest institutional RYTM shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

291

Total Reported Value

$8.44B

Largest Holder

Ra Capital Management, L.P.

Largest Position

$740.22M

Insider Transactions (90d)

34

Latest Filing Quarter

Q2 2026

New Institutional Positions

52

Funds Exiting Positions

1

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Ra Capital Management, L.P.6.43%6,666,837$740,218,912$653,416,694-$86,802,218-11.73%
Blackrock, Inc.0.01%6,156,902$683,600,828$603,437,965-$80,162,863-11.73%
Baker Bros. Advisors Lp3.12%5,604,483$622,265,747$549,295,379-$72,970,368-11.73%
Primecap Management Co/Ca/0.21%3,168,853$351,837,748$310,579,283-$41,258,465-11.73%
Vanguard Portfolio Management Llc0.02%3,136,895$348,289,452$307,447,079-$40,842,373-11.73%
Vanguard Capital Management Llc0.01%3,005,977$333,753,626$294,615,806-$39,137,820-11.73%
Jpmorgan Chase & Co0.02%2,652,746$292,178,898$259,995,635-$32,183,263-11.01%
Perceptive Advisors Llc4.46%2,586,295$287,156,334$253,482,773-$33,673,561-11.73%
State Street Corp0.01%2,573,529$285,728,722$252,231,577-$33,497,145-11.72%
Price T Rowe Associates Inc0.03%2,566,171$284,923,000$251,510,420-$33,412,580-11.73%
Westfield Capital Management Co Lp0.80%2,208,595$245,220,303$216,464,396-$28,755,907-11.73%
Goldman Sachs Group Inc0.02%2,126,502$236,105,516$208,418,461-$27,687,055-11.73%
Federated Hermes, Inc.0.29%1,785,716$198,268,047$175,018,025-$23,250,022-11.73%
Polar Capital Holdings Plc0.52%1,663,632$184,713,061$163,052,572-$21,660,489-11.73%
Geode Capital Management, Llc0.01%1,533,698$170,320,392$150,317,741-$20,002,651-11.74%
Capital Research Global Investors0.02%1,532,303$170,131,602$150,181,017-$19,950,585-11.73%
Citadel Advisors Llc0.08%1,263,652$140,303,282$123,850,533-$16,452,749-11.73%
Checkpoint Capital L.P.33.79%1,186,000$131,681,580$116,239,860-$15,441,720-11.73%
Siren, L.L.C.2.56%1,136,275$126,160,613$111,366,313-$14,794,300-11.73%
Morgan Stanley0.01%1,112,240$123,492,178$109,010,642-$14,481,536-11.73%
Fmr Llc0.00%1,025,840$113,899,059$100,542,578-$13,356,481-11.73%
Pictet Asset Management Holding Sa0.10%957,785$106,252,095$93,872,508-$12,379,587-11.65%
Woodline Partners Lp0.26%758,891$84,259,668$74,378,907-$9,880,761-11.73%
Janus Henderson Group Plc0.04%918,153$79,886,248$89,988,176+$10,101,928+12.65%
Alliancebernstein L.P.0.03%894,723$77,814,059$87,691,801+$9,877,742+12.69%
Clearbridge Investments, Llc0.06%696,473$77,329,368$68,261,319-$9,068,049-11.73%
Rock Springs Capital Management Lp3.75%692,598$76,899,156$67,881,530-$9,017,626-11.73%
Norges Bank0.01%685,844$76,149,259$67,219,570-$8,929,689-11.73%
Charles Schwab Investment Management Inc0.01%552,738$61,370,500$54,173,851-$7,196,649-11.73%
Integral Health Asset Management, Llc2.51%550,000$61,066,500$53,905,500-$7,161,000-11.73%
Invesco Ltd.0.00%543,271$60,319,379$53,245,991-$7,073,388-11.73%
Northern Trust Corp0.01%540,332$59,993,061$52,957,939-$7,035,122-11.73%
Wellington Management Group Llp0.01%488,747$54,265,580$47,902,093-$6,363,487-11.73%
Vanguard Fiduciary Trust Co0.01%445,723$49,488,625$43,685,311-$5,803,314-11.73%
Loomis Sayles & Co L P0.06%434,102$48,198,345$42,546,337-$5,652,008-11.73%
Candriam S.C.A.0.22%433,025$48,032,508$42,440,780-$5,591,728-11.64%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.01%541,450$47,089,907$53,067,515+$5,977,608+12.69%
Squarepoint Ops Llc0.09%422,921$46,956,919$41,450,487-$5,506,432-11.73%
Point72 Asset Management, L.P.0.07%414,210$45,989,736$40,596,722-$5,393,014-11.73%
Sofinnova Investments, Inc.2.42%408,027$45,303,238$39,990,726-$5,312,512-11.73%
Ameriprise Financial Inc0.01%401,634$44,593,674$39,364,148-$5,229,526-11.73%
Adage Capital Partners Gp, L.L.C.0.06%397,000$44,078,910$38,909,970-$5,168,940-11.73%
Bank Of New York Mellon Corp0.01%394,044$43,750,776$38,620,252-$5,130,524-11.73%
Braidwell Lp1.57%381,128$42,316,642$37,354,355-$4,962,287-11.73%
Artisan Partners Limited Partnership0.06%354,816$39,395,220$34,775,516-$4,619,704-11.73%
Bank Of America Corp0.00%325,470$36,136,934$31,899,315-$4,237,619-11.73%
Orbimed Advisors Llc0.68%322,900$35,851,587$31,647,429-$4,204,158-11.73%
Millennium Management Llc0.02%316,719$35,165,311$31,041,629-$4,123,682-11.73%
Silverarc Capital Management, Llc3.85%311,461$34,581,515$30,526,293-$4,055,222-11.73%
Voya Investment Management Llc0.03%272,974$30,308,303$26,754,182-$3,554,121-11.73%
Showing 50 of 291

Frequently asked questions about RYTM

  • Who owns the most RYTM stock?

    The largest holders of RYTM are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for RHYTHM PHARMACEUTICALS INC (RYTM).

  • Is RYTM widely held by superinvestors?

    Many widely followed stocks like RYTM appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly RYTM is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.